Jorge Santos da Silva - Feb 27, 2025 Form 4 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role: Chief Executive Officer, Director
Signature: /s/ Matthias Bodenstedt, Attorney-in-fact for Jorge Santos da Silva
Stock symbol: MLTX
Transactions as of: Feb 27, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/3/2025, 09:08 PM
Previous filing: Feb 29, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLTX	Class A ordinary shares, par value $0.0001 per share	Award	$0	+95.8K	+3.21%	$0.00	3.08M	Feb 27, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock that vest in four equal annual installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.